486 related articles for article (PubMed ID: 18180350)
21. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
22. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
Soustre J; Rodier MH; Imbert-Bouyer S; Daniault G; Imbert C
J Antimicrob Chemother; 2004 Mar; 53(3):522-5. PubMed ID: 14749343
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
24. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
[TBL] [Abstract][Full Text] [Related]
25. Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation.
Lee JA; Robbins N; Xie JL; Ketela T; Cowen LE
PLoS Genet; 2016 Nov; 12(11):e1006452. PubMed ID: 27870871
[TBL] [Abstract][Full Text] [Related]
26. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
27. The cell wall protein Rhd3/Pga29 is over-expressed in Candida albicans upon micafungin treatment.
Vavala E; Mignogna G; Spano F; Stringaro A; Colone M; Sanguinetti M; Maras B; Angiolella L
J Chemother; 2013 Dec; 25(6):332-40. PubMed ID: 24090751
[TBL] [Abstract][Full Text] [Related]
28. Glutathione metabolism in Candida albicans resistant strains to fluconazole and micafungin.
Maras B; Angiolella L; Mignogna G; Vavala E; Macone A; Colone M; Pitari G; Stringaro A; Dupré S; Palamara AT
PLoS One; 2014; 9(6):e98387. PubMed ID: 24896636
[TBL] [Abstract][Full Text] [Related]
29. Effect of progesterone on Candida albicans vaginal pathogenicity.
Alves CT; Silva S; Pereira L; Williams DW; Azeredo J; Henriques M
Int J Med Microbiol; 2014 Nov; 304(8):1011-7. PubMed ID: 25183575
[TBL] [Abstract][Full Text] [Related]
30. Pga26 mediates filamentation and biofilm formation and is required for virulence in Candida albicans.
Laforet L; Moreno I; Sánchez-Fresneda R; Martínez-Esparza M; Martínez JP; Argüelles JC; de Groot PW; Valentín-Gomez E
FEMS Yeast Res; 2011 Aug; 11(5):389-97. PubMed ID: 21439008
[TBL] [Abstract][Full Text] [Related]
31. Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans.
Wu S; Jia W; Lu Y; Jiang H; Huang C; Tang S; Du L
BMC Microbiol; 2024 Jun; 24(1):196. PubMed ID: 38849761
[TBL] [Abstract][Full Text] [Related]
32. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
[TBL] [Abstract][Full Text] [Related]
33. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
[TBL] [Abstract][Full Text] [Related]
35. Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.
Ben-Ami R; Kontoyiannis DP
Virulence; 2012; 3(1):95-7. PubMed ID: 22286697
[TBL] [Abstract][Full Text] [Related]
36. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
Lee JH; Kim YG; Lee J
Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
[TBL] [Abstract][Full Text] [Related]
39. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains.
Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y
Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517
[TBL] [Abstract][Full Text] [Related]
40. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
Sasse C; Dunkel N; Schäfer T; Schneider S; Dierolf F; Ohlsen K; Morschhäuser J
Mol Microbiol; 2012 Nov; 86(3):539-56. PubMed ID: 22924823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
